Drug name - Valturna

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8168616 NOVARTIS Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension Jul, 2026

(3 years from now)

More Information on Dosage
Strength Dosage Availability
EQ 150MG BASE;160MG TABLET;ORAL Discontinued
EQ 300MG BASE;320MG TABLET;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.